Targeting the Myocardial Microenvironment: Novel Antiviral Strategies and Therapeutic Perspectives for Coxsackievirus B–Induced Myocarditis
Journal of the American Heart Association · 07.07.2026 · 15 (13)
DOI: 10.1161/jaha.125.048926 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 07.07.2026. Verfasst von Yang Yue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics, School of Stomatology China Medical University Shenyang Liaoning China. Hauptthemen laut MEDLINE: Myocarditis, Coxsackievirus Infections, Antiviral Agents, Enterovirus B, Human. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Coxsackievirus B3 is a primary cause of viral myocarditis, with ≈20% of cases progressing to dilated cardiomyopathy. Despite its clinical significance, therapeutic strategies remain limited. The pathogenesis of coxsackievirus B3–induced myocarditis is complex, centered on the virus's ability to hijack the myocardial microenvironment, which is composed of various cell types and their interactions, influencing disease progression and outcomes. This review comprehensively summarizes the changes in fibroblasts, endothelial cells, mast cells, monocytes/macrophages, neutrophils, dendritic cells, natural killer cells, and lymphocytes within the myocardial microenvironment during coxsackievirus B3 infection, highlighting their critical roles in disease development. Additionally, it provides an overview of recent findings on potential therapeutic approaches targeting the myocardial microenvironment. Targeted regulation of cellular functions, key molecular pathway intervention, intelligent delivery system development, and noninvasive biomarker identification, combined with organoid and artificial intelligence technologies, pave the way for precision therapy and diagnosis centered on myocardial microenvironment remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthodontics, School of Stomatology China Medical University Shenyang Liaoning China.
- Department of Anesthesiology Shengjing Hospital of China Medical University Shenyang Liaoning China.
- Department of Pathology The Fourth Affiliated Hospital of China Medical University Shenyang Liaoning China.
- Department of Pediatrics Shengjing Hospital of China Medical University Shenyang Liaoning China.
- Department of Preventive Dentistry, School and Hospital of Stomatology, Liaoning Provincial Key laboratory of Oral Diseases China Medical University Shenyang Liaoning China.
- Department of Rehabilitation Shengjing Hospital of China Medical University Shenyang Liaoning China.
ORCID-Profile: Chengda Wei, Lu Liu, Ce Wang
Zitieren
APA
Yue, Y., Wei, C., Ding, M., Zhang, X., Li, X., Liu, L., Liu, C., & Wang, C. (2026). Targeting the Myocardial Microenvironment: Novel Antiviral Strategies and Therapeutic Perspectives for Coxsackievirus B–Induced Myocarditis. Journal of the American Heart Association, 15(13). https://doi.org/10.1161/jaha.125.048926
Vancouver
Yue Y, Wei C, Ding M, Zhang X, Li X, Liu L, et al. Targeting the Myocardial Microenvironment: Novel Antiviral Strategies and Therapeutic Perspectives for Coxsackievirus B–Induced Myocarditis. Journal of the American Heart Association. 2026;15(13). doi:10.1161/jaha.125.048926
BibTeX
@article{Yue2026,
author = {Yue, Yang and Wei, Chengda and Ding, Mengmeng and Zhang, Xiuwei and Li, Xuemei and Liu, Lu and Liu, Chengcheng and Wang, Ce},
title = {Targeting the Myocardial Microenvironment: Novel Antiviral Strategies and Therapeutic Perspectives for Coxsackievirus B–Induced Myocarditis},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {13},
doi = {10.1161/jaha.125.048926}
}
EUVIMED